Loading...
Back to narrative

Update shared on13 Oct 2025

Fair value Increased 1.00%
AnalystConsensusTarget's Fair Value
US$390.20
10.7% undervalued intrinsic discount
13 Oct
US$348.55
Loading
1Y
-9.7%
7D
-3.2%

Analysts have modestly raised their price target for Everest Group, citing a higher fair value estimate of $390.20, improved sector stability, and solid third-quarter trends. However, there remains ongoing cautiousness about profit margins and industry fundamentals.

Analyst Commentary

Recent Street research presents a nuanced picture for Everest Group, with both optimistic and cautious viewpoints emerging as price targets are revised and sector fundamentals weighed. Below is a summary of current analyst sentiment:

Bullish Takeaways
  • Bullish analysts have raised their price targets multiple times in recent months. This highlights confidence in the company's execution and ability to derive value amid sector shifts.
  • The third quarter was described as "relatively calm." The absence of major catastrophic events contributed to earnings stability and supported an improved fair value estimate.
  • Fundamental improvements in some commercial lines, including a lighter mix of property renewals, are expected to help with pricing power and potentially shore up profitability.
  • Underwriting results in the reinsurance business were reported as better than expected in recent quarters. This contributed positively to outlooks and justified upward price adjustments.
Bearish Takeaways
  • Bearish analysts continue to express caution regarding the profitability of certain lines. They point out that fundamentals across the board remain uneven with weak margin outlooks for some segments.
  • There is skepticism about declining property pricing. Some suggest that current pricing trends are irrational when set against rising loss averages.
  • Analysts stress that the sector is in transition. Macro uncertainties and headwinds are likely to persist, pressuring valuation multiples and growth expectations.
  • There is concern that for reinsurers, including Everest Group, the cost of capital may outpace returns by 2027. This could lead to long-term margin compression unless industry dynamics improve.

What's in the News

  • Wells Fargo raised Everest Group's price target to $375 from $362 following its second-quarter report. The firm noted strong reinsurance results despite mixed performance in other segments (Wells Fargo).
  • Everest Group repurchased 580,883 shares between April 1, 2025 and June 30, 2025 for $200 million, completing 65.14% of the buyback program announced in 2004 (Company Filing).

Valuation Changes

  • Fair Value: The fair value estimate has risen slightly, moving from $386.33 to $390.20 per share.
  • Discount Rate: This has decreased marginally from 6.82% to 6.78%, indicating a slightly lower risk premium applied in models.
  • Revenue Growth: Revenue growth projections have softened further, shifting from -1.71% to -1.75% year-over-year.
  • Net Profit Margin: The net profit margin estimate declined, going from 21.68% to 21.19%.
  • Future P/E: The projected future price-to-earnings ratio has increased slightly from 4.91x to 5.07x.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.